Blast Count Matters: TP53 Wild-Type Myelodysplastic Syndrome with 10-19% Blasts is Less Aggressive than Acute Myeloid Leukemia Irrespective of Molecular Risk
LABORATORY INVESTIGATION(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
LABORATORY INVESTIGATION(2023)